Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
-
Waking from the “Coma of COVID-19”
What should the “New Normal” look like?Emil W. Ciurczak, DoraMaxx Consulting 06.07.21
-
Information Technology | QA/QC | Regulatory Affairs
The Importance of Data Integrity Risk Assessment
Executing Data Integrity Risk Assessments for systems that generate and store both paper (manual)-based systems as well as computer-based and hybrid systems.Paul Mason, Ph.D., Lachman Consultants 06.07.21
-
Motivating Your Scientists and Engineers
It’s more than just money or stock.David G. Jensen, Contributing Editor 06.07.21
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The modernization of advanced therapy manufacturing.Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
-
The Word ‘Innovation’ Probably Doesn’t Mean What You Think It Does
Innovation in manufacturing can come in many forms.Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 05.05.21
-
Analytical Services
Too Much of a Good Thing?
Watch out for that pendulum!Emil W. Ciurczak, DoraMaxx Consulting 05.05.21
-
The Changing Nature of Communications
Is Zoom burnout leading to a resurgence of the “good-ol” phone call?David G. Jensen, Contributing Editor 05.05.21
-
Ensuring Pharma Manufacturing Quality
How today’s life sciences manufacturers can effectively monitor processes, integrate with sub-contractors and align with regulatory reporting requirements.Shahid Manzur, Principal, EY Consulting 05.05.21
-
Biologics, Proteins, Vaccines | Regulatory Affairs
What Will Change at FDA for 2021?
(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21
-
Drug Delivery
The Ever-Evolving World of Combination Products
Looking at the benefits and challenges of the trend towards combination products.Ricki A. Chase, M.S, Lachman Consultants 04.01.21
-
Professional Etiquette at Two Critical Moments
Starting, or leaving, a job presents unique challenges.David G. Jensen, Contributing Editor 04.01.21
-
Regulatory Affairs
Post-Pandemic Regulations
Envisioning clinical development regulatory practices in a post-pandemic world.Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 04.01.21
-
Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown and Joe Rymsza, IQVIA 03.01.21
-
Biologics, Proteins, Vaccines
Vaccines and Return-To-Normalcy
Planning for a future in which COVID-19 won’t simply ‘disappear.’Ben Locwin, Contributing Editor 03.01.21
-
Chemistry | Laboratory Testing
-
Stopping Career Burnout in Its Tracks
How to recognize and successfully combat—even avoid—burnout before it takes its toll.Ryan Raver, PhD, Contributing Editor 03.01.21
-
Aseptic Processing | Facilities | Fill/Finish | Parenterals
The Future of Pharmaceutical Manufacturing
Innovative multi-product facility and equipment design.Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21
-
Solid Dosage/Creams/Ointments
Recent Advances in Solid Dispersion Technologies
Improving the bioavailability and therapeutic efficiency of poorly soluble drugs.José L. Toro, Directory, Lachman Consultants 01.27.21
-
Biologics, Proteins, Vaccines
Vaccines 2021
Looking at the behavioral economics of vaccinations.Ben Locwin, Contributing Editor 01.27.21
